Hunan Warrant Pharmaceutical Co.,Ltd (688799.SS)
CNY 42.93
(-3.83%)
CNY 42.93
(-3.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.43 Billion | 1.29 Billion | 1.14 Billion | 950.62 Million | 824.64 Million | 613.24 Million |
| Cost of Revenue | 504.55 Million | 417.37 Million | 316.63 Million | 255.51 Million | 243.83 Million | 185.31 Million |
| Gross Profit | 928.23 Million | 875.28 Million | 829.96 Million | 695.11 Million | 580.81 Million | 427.93 Million |
| Operating Expenses | 691.12 Million | 686.86 Million | 647.64 Million | 522.7 Million | 448.24 Million | 318.31 Million |
| Selling, General and Administrative Expenses | 577.51 Million | 556.91 Million | 556.86 Million | 442.47 Million | 378.56 Million | 268.59 Million |
| Research and Development Expenses | 105.78 Million | 88.66 Million | 70.05 Million | 63.65 Million | 45.42 Million | 25.61 Million |
| Other Expenses | 7.81 Million | 41.27 Million | 20.72 Million | 16.56 Million | 24.25 Million | -107.76 Thousand |
| Cost and Expenses | 1.19 Billion | 1.1 Billion | 964.27 Million | 778.21 Million | 692.07 Million | 503.62 Million |
| Operating Income | 237.11 Million | 196 Million | 181.89 Million | 160.87 Million | 127.72 Million | 104.22 Million |
| Interest Expense | 120.08 Thousand | 163.16 Thousand | 166.51 Thousand | 50.94 Thousand | 12.75 Thousand | 671.06 Thousand |
| Income Tax Expense | 36.84 Million | 21.57 Million | 19.26 Million | 19.45 Million | 11.64 Million | 15.63 Million |
| Earnings before Tax | 229.87 Million | 194.96 Million | 180.03 Million | 164.48 Million | 127.65 Million | 104.12 Million |
| Net Income | 211.31 Million | 182.8 Million | 160.76 Million | 145.02 Million | 116.01 Million | 88.48 Million |
| Earnings Per Share Basic | 2.25 | 1.95 | 1.71 | 1.55 | 1.24 | 1.26 |
| Earnings Per Share Diluted | 2.25 | 1.95 | 1.71 | 1.55 | 1.24 | 1.26 |
| Weighted Average Shares Outstanding | 93.91 Million | 93.8 Million | 93.8 Million | 93.8 Million | 93.8 Million | 70.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 93.91 Million | 93.8 Million | 93.8 Million | 93.8 Million | 93.8 Million | 70.22 Million |
| Gross Margin | 0.65 | 0.68 | 0.72 | 0.73 | 0.70 | 0.70 |
| EBIT Margin | 0.20 | 0.19 | 0.19 | 0.22 | 0.19 | 0.22 |
| Profit Margin | 0.15 | 0.14 | 0.14 | 0.15 | 0.14 | 0.14 |
| EBITDA | 292.03 Million | 248.9 Million | 216.54 Million | 194.19 Million | 145.89 Million | 122.81 Million |
| Earnings Before Tax Margin | 0.17 | 0.15 | 0.16 | 0.17 | 0.15 | 0.17 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 324.36 Million | 365.69 Million | 369.57 Million | 369.64 Million | 1.41 Billion | 334.68 Million |
| Cost of Revenue | 127.75 Million | 141.8 Million | 133.12 Million | 139.49 Million | 532.23 Million | 109.92 Million |
| Gross Profit | 196.61 Million | 223.88 Million | 236.45 Million | 230.14 Million | 881.28 Million | 224.76 Million |
| Operating Expenses | 163.88 Million | 166.31 Million | 188.9 Million | 189.18 Million | 678.51 Million | 173.08 Million |
| Selling, General and Administrative Expenses | 129.96 Million | 102.8 Million | 156.32 Million | 161.3 Million | - | 170.61 Million |
| Research and Development Expenses | 34.08 Million | 35.04 Million | 31.42 Million | 25.46 Million | - | 20.95 Million |
| Other Expenses | 163.98 Thousand | -83.92 Thousand | -1.15 Million | -2.41 Million | -6.09 Million | -107.11 Thousand |
| Cost and Expenses | 291.63 Million | 308.12 Million | 322.03 Million | 328.68 Million | 1.21 Billion | 283 Million |
| Operating Income | 32.72 Million | 53.87 Million | 47.54 Million | 40.96 Million | 202.76 Million | 50.33 Million |
| Interest Expense | - | - | - | - | 120.08 Thousand | - |
| Income Tax Expense | 2.36 Million | 6.95 Million | 14.78 Million | 11.18 Million | 36.84 Million | 8.82 Million |
| Earnings before Tax | 49.42 Million | 53.78 Million | 70.31 Million | 60.64 Million | 234.92 Million | 50.22 Million |
| Net Income | 45.61 Million | 52.74 Million | 60.05 Million | 53.04 Million | 211.31 Million | 46.06 Million |
| Earnings Per Share Basic | 0.49 | 0.56 | 0.64 | 0.57 | - | 0.49 |
| Earnings Per Share Diluted | 0.49 | 0.56 | 0.64 | 0.57 | - | 0.49 |
| Weighted Average Shares Outstanding | 93.8 Million | 93.8 Million | 93.8 Million | 93.8 Million | 93.8 Million | 93.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 93.8 Million | 93.8 Million | 93.8 Million | 93.8 Million | 93.8 Million | 93.8 Million |
| Gross Margin | 0.61 | 0.61 | 0.64 | 0.62 | 0.62 | 0.67 |
| EBIT Margin | 0.15 | 0.17 | 0.20 | 0.16 | - | 0.16 |
| Profit Margin | 0.14 | 0.14 | 0.16 | 0.14 | 0.15 | 0.14 |
| EBITDA | 49.42 Million | 60.91 Million | 73.6 Million | 58.19 Million | - | 52.86 Million |
| Earnings Before Tax Margin | 0.10 | 0.15 | 0.13 | 0.11 | 0.14 | 0.15 |
BZDLF
HSCS
2001
ELN
9616
AKG